Transjugular Intrahepatic Portosystemic Shunt


Article Author:
Nikhil Amesur


Article Editor:
Paula Novelli


Editors In Chief:
Jessica Snowden
Asif Noor
H Davies


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
2/20/2019 12:50:39 PM

Introduction

Transjugular intrahepatic portosystemic shunt (TIPS) is now a well established percutaneous means of decreasing portal hypertension. The major clinical indications for transjugular intrahepatic portosystemic shunt are refractory variceal hemorrhage and refractory ascites. The shunt itself is created by placing a stent between the portal vein and the hepatic vein. The resultant shunting of portal venous flow to the systemic circulation helps reduce the portosystemic gradient and alleviate bleeding and ascites without changing the extrahepatic anatomy.

History and Development

The transjugular intrahepatic portosystemic shunt was initially described in 1969, originally by prolonged balloon dilation of a percutaneously created tract between the portal and hepatic veins. Unfortunately, short patency of the track remained a major clinical hurdle to its widespread use. The development of balloon expandable metallic stents and the subsequent introduction of flexible bare-metal stents helped improve patency rates. Intimal hyperplasia within the stent, especially at the hepatic venous end, required frequent secondary interventions such as balloon dilation and re-stenting. Early thrombosis was felt to be secondary to placing the transjugular intrahepatic portosystemic shunt across a major bile duct. Advances in stent technology and the introduction of polytetrafluoroethylene-covered stents over a decade ago has led to further increase in clinical patency and improved long-term results with TIPS.[1][2][3][4]

Anatomy

A thorough understanding of the anatomy and patency of vessels as it relates to portal hypertension, including portal venous anatomy, hepatic venous anatomy, and pathways of collateral venous/variceal flow are paramount. These need to be evaluated for before undertaking a transjugular intrahepatic portosystemic shunt procedure as it can have a significant impact on the procedure itself. The presence or absence of shunts such as splenorenal shunts should be assessed before undertaking a transjugular intrahepatic portosystemic shunt.

Indications

Indications for TIPS

  • Secondary prevention of variceal hemorrhage (1A level of evidence)
  • Refractory Ascites (1A level of evidence)
  • Refractory hepatic hydrothorax
  • Budd-Chiari syndrome
  • Hepatorenal syndrome
  • Hepato-pulmonary syndrome 

Contraindications

Absolute Contraindications

  • Primary prevention of variceal hemorrhage
  • Congestive heart failure
  • Pulmonary hypertension
  • Severe sepsis
  • Biliary obstruction
  • Extensive hepatic cysts

Relative Contraindications

  • Liver cancer
  • Portal vein thrombosis or hepatic vein occlusion
  • Severe coagulopathy and/or thrombocytopenia
  • Advanced hepatic encephalopathy

Relative Contraindications for TIPS

  • Primary prevention of variceal bleeding
  • Congestive heart failure/Pulmonary hypertension
  • Severe pulmonary hypertension
  • Unrelieved biliary obstruction
  • Multiple hepatic cysts
  • Portal vein thrombosis
  • Hepatic encephalopathy
  • Central hepatocellular carcinoma

Equipment

The procedure should be undertaken in an interventional suite with adequate fluoroscopy and ultrasound equipment. Basic angiographic supplies such as access needles, guide wires, catheters, and balloons should be on hand. Equipment specifically designed for transjugular intrahepatic portosystemic shunt procedures should be on hand. Covered stents specially designed for TIPS in appropriate sizes need to be on hand. Additionally, embolization materials including coils, plugs and sclerosis agents should be available to embolize varices/shunts. Physiological monitoring equipment and adequate personnel are needed, including nurses and technologists.

Personnel

Experienced Interventionalists should perform a transjugular intrahepatic portosystemic shunt in a dedicated interventional suite with adequate personnel, including experienced technologists and nursing staff. Ideally, the anesthesiology team should be available to provide anesthesia as appropriate. A multi-disciplinary team approach is very useful in the management of these patients including interventional radiology, gastrointestinal (hepatology) medicine, and transplantation surgery as they each add their unique management skills.

Preparation

A thorough clinical evaluation of the patient begins in the interventional radiology clinic, but many times has to be performed emergently in the case of bleeding. A baseline laboratory evaluation, including liver function tests, renal function, and coagulation status, needs to be obtained. Underlying coagulation issues should be corrected. In cases of impaired renal function pre-hydration as well as the use of lower osmolality nonionic contrast agents should be used. Pre-procedure cross-sectional imaging is important to document patency of the portal and hepatic veins and  to exclude the presence of tumor along the parenchymal tract.  Large-volume ascites may be drained immediately before the procedure, especially if advanced techniques need to be utilized such as placement of a percutaneous guide wire into the portal vein. The MELD (model for end-stage liver disease) score should be calculated, as it is used as a predictor of post-TIPS mortality. It takes into consideration creatinine, bilirubin, and INR. A score above 18 predicts significantly higher mortality within 3 months of TIPS. Finally, all the risks and benefits of the procedure need to be carefully discussed with the patient, family, and referring physician.

Technique

While moderate, conscious sedation may be used for the procedure, general anesthesia is preferred. Pre-procedure antibiotics are necessary. A right internal jugular approach is preferred to cannulate the central venous system. An angled catheter is used to cannulate the right hepatic vein. A balloon occlusion hepatic venogram with CO2 is performed to opacify the portal venous system and provide a fluoroscopic target for portal vein entry with the needle. Several commercial transjugular intrahepatic portosystemic shunt kits are available, and the included needle is used under fluoroscopic/ultrasound guidance to regularly access the right portal vein from the right hepatic vein. Middle and left hepatic veins, as well as the left portal vein, may be used. Real-time ultrasound guidance can help visualize the passage of the needle and portal vein entry. Aspiration of blood, followed by contrast injection, is used to confirm appropriate portal venous access. The ideal entry point in the portal vein is 1 to 2 centimeters from the main bifurcation to avoid an extra-hepatic puncture and possible hemoperitoneum. If the portal vein cannot be accessed in this manner, a percutaneous transhepatic guidewire can be placed into the portal vein and be used as a fluoroscopic target for portal vein entry. An angiographic catheter is advanced into the portal vein for venogram to confirm portal vein access and to confirm suitable location. Pressure measurements in the portal vein and right atrium are obtained to calculate the initial portal to systemic gradient. The initial pressures may be low in patients with a competing spleno-renal shunt, and they may need to be embolized. The tract is then dilated to 8 to 10 millimeters. A partially covered stent is the preferred stent, with the uncovered portion being placed in the portal venous end and the covered end extending to the junction of the hepatic vein and inferior vena cava (IVC). Care should be taken to avoid extending the stent significantly into the IVC or far down into the portal vein as this may impact future liver transplantation. If there is persistent filling of varices after TIPS placement, they should be embolized with coils or plug. They also can be sclerosed at this time to prevent ongoing variceal bleeding. Final TIPS gradients should be recorded to help in future interventions.[5][6][7][8]

The patient should recover in a closely monitored setting, depending on the clinical status. Liver enzymes should be closely followed to monitor for any hepatic dysfunction post-TIPS placement. A TIPS Doppler ultrasound study should be obtained within 48 to 72 hours of TIPS placement. Earlier studies may be inaccurate as residual air bubbles within the wall of the polytetrafluoroethylene material may prevent adequate ultrasound penetration and may simulate decreased or absent flow within the newly created shunt. This study can serve as a baseline for follow-up surveillance scans to assess for shunt dysfunction and the need for follow-up intervention.

Doppler ultrasound velocities of greater than 190 centimeters per second or lower than 90 centimeters per second are associated with shunt dysfunction. Other concerning findings are a change (increase or decrease) in velocity of greater than 50 centimeters per second from baseline. Depending on the clinical scenario and the ultrasound findings a TIPS venogram with direct pressure measurements should be pursued in the angiography suite. Intimal hyperplasia within the stent can be treated with balloon dilation and or re-stenting to improve TIPS flow.[9][10][11][12]

Complications

Complications from a transjugular intrahepatic portosystemic shunt can be broadly categorized into immediate, procedure-related clinical complications and longer-term complications.

Immediate Complications

  • Puncture related bleeds, including hemoperitoneum (may need percutaneous embolization or surgical intervention)
  • Stent malposition/migration
  • Early shunt thrombosis due to technical issues or bile duct injury
  • Shunt-related encephalopathy (30% to 46%)
  • Deterioration of hepatic function (may be treated with shunt narrowing or in severe cases closure of the shunt)
  • Shunt stenosis (leading to secondary intervention with balloon dilation or re-stenting)

Long-term Complications

  • Intimal hyperplasia within the TIPS (may lead to reduced flow and recurrence of portal hypertension in the patient)
  • Similarly, complete TIPS thrombosis (may lead to recurrence of portal hypertension)
  • Both treated by re-establishing TIPS patency with balloon dilation and re-stenting

Clinical Significance

All transjugular intrahepatic portosystemic shunt patients should receive close clinical multi-disciplinary follow-up, both by the interventional radiologist and hepatologist. Regular noninvasive imaging based on local protocols with ultrasound is imperative in this patient population. Patient follow-up may indicate transplant surgery and include being listed for a potential liver transplant, depending on their clinical status.

TIPS has established itself as a percutaneous, minimally invasive means of treating a patient with severe complications of portal hypertension.

Enhancing Healthcare Team Outcomes

The managment of patients with portal hypertension is with a multidisciplinary team that consists of a pathologist, radiologist, gastroenterologist, general surgeon, dietitian, and an internist. As outpatients the majority of them are followed by the nurse practitioner and primary care provider. Some of these patients may develop variceal bleeding and require TIPS. Only experienced interventionalists should perform a transjugular intrahepatic portosystemic shunt in a dedicated interventional suite with adequate personnel, including experienced technologists and nursing staff. Ideally, the anesthesiology team should be available to provide anesthesia as appropriate. A multi-disciplinary team approach is very useful in the management of these patients including interventional radiology, gastrointestinal (hepatology) medicine, and transplantation surgery as they each add their unique management skills. Because TIPS is not 100% effective, patients need close follow up and the transplant team consulted. Some of these patients may benefit from a liver transplant. The overall outcome of patients with portal hypertension is poor. Liver transplant is not the ideal solution because of expense and shortage of organs.[13](Level V)


  • Image 1581 Not availableImage 1581 Not available
    Contributed by Scott Jones, MD
Attributed To: Contributed by Scott Jones, MD

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Transjugular Intrahepatic Portosystemic Shunt - Questions

Take a quiz of the questions on this article.

Take Quiz
Which describes a transjugular intrahepatic portosystemic shunt (TIPS) as used in treatment of liver failure?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient with long-standing alcoholism presents to the emergency department with severe hematemesis. He is known to have esophageal varices, and this is his fifth visit this year. In the past, he has undergone sclerotherapy without much success. This time it is decided to treat him with transjugular intrahepatic portosystemic shunting. Before the transjugular intrahepatic portosystemic shunt (TIPS) procedure, what else should be done besides hydration?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not an indication for transjugular intrahepatic portosystemic shunt?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is an absolute contraindication for transjugular intrahepatic portosystemic shunt placement?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Transjugular Intrahepatic Portosystemic Shunt - References

References

Khoury T,Massarwa M,Daher S,Benson AA,Hazou W,Israeli E,Jacob H,Epstein J,Safadi R, Endoscopic Ultrasound-Guided Angiotherapy for Gastric Varices: A Single Center Experience. Hepatology communications. 2019 Feb;     [PubMed]
Lattanzi B,D'Ambrosio D,Merli M, Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration. Journal of clinical and experimental hepatology. 2019 Jan-Feb;     [PubMed]
Sonavane AD,Amarapurkar DN,Rathod KR,Punamiya SJ, Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome. Journal of clinical and experimental hepatology. 2019 Jan-Feb;     [PubMed]
Chen SL,Hu P,Lin ZP,Zhao JB, The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy. Gastroenterology research and practice. 2019;     [PubMed]
Darrow AW,Gaba RC,Lokken RP, Transhepatic Revision of Occluded Transjugular Intrahepatic Portosystemic Shunt Complicated by Endotipsitis. Seminars in interventional radiology. 2018 Dec;     [PubMed]
Valentin N,Weisberg I, The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis. European journal of gastroenterology     [PubMed]
Bertino F,Hawkins CM,Shivaram G,Gill AE,Lungren MP,Reposar A,Sze DY,Hwang GL,Koo K,Monroe E, Technical Feasibility and Clinical Effectiveness of Transjugular Intrahepatic Portosystemic Shunt Creation in Pediatric and Adolescent Patients. Journal of vascular and interventional radiology : JVIR. 2019 Feb;     [PubMed]
David A,Liberge R,Meyer J,Morla O,Leaute F,Archambeaud I,Gournay J,Trewick D,Frampas E,Perret C,Douane F, Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagnostic and interventional imaging. 2019 Jan 30;     [PubMed]
Wong K,Ozeki K,Kwong A,Patel BN,Kwo P, The effects of a transjugular intrahepatic portosystemic shunt on the diagnosis of hepatocellular cancer. PloS one. 2018;     [PubMed]
Nardelli S,Gioia S,Ridola L,Riggio O, Radiological Intervention for Shunt Related Encephalopathy. Journal of clinical and experimental hepatology. 2018 Dec;     [PubMed]
Downing TM,Khan SN,Zvavanjanja RC,Bhatti Z,Pillai AK,Kee ST, Portal Venous Interventions: How to Recognize, Avoid, or Get Out of Trouble in Transjugular Intrahepatic Portosystemic Shunt (TIPS), Balloon Occlusion Sclerosis (ie, BRTO), and Portal Vein Embolization (PVE). Techniques in vascular and interventional radiology. 2018 Dec;     [PubMed]
Khan F,Mehrzad H,Tripathi D, Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective. Journal of translational internal medicine. 2018 Sep;     [PubMed]
Leng X,Zhang F,Zhang M,Guo H,Yin X,Xiao J,Wang Y,Zou X,Zhuge Y, Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt. European journal of gastroenterology     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Pediatric-Infectious Diseases. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Pediatric-Infectious Diseases, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Pediatric-Infectious Diseases, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Pediatric-Infectious Diseases. When it is time for the Pediatric-Infectious Diseases board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Pediatric-Infectious Diseases.